Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezerra Cream Post-TCA Peel Safety and Effectiveness
NCT06255431Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- May 2023
- Primary completion
- May 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Skin aging comparing Ezerra Cream Side with Vehicle Cream Side (2 arms). Primary endpoints: Transepidermal Water Loss at Day 7, Skin Capacitance at Day 7 and 1 more. Started May 2023; status: completed.
02
Drugs
Ezerra cream
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT06255431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06255431.